Bifogade filer
Kurs & Likviditet
Kalender
2024-02-29 | Bokslutskommuniké 2023 |
2023-11-02 | Kvartalsrapport 2023-Q3 |
2023-07-20 | Kvartalsrapport 2023-Q2 |
2023-05-08 | Ordinarie utdelning ADDV A 0.00 SEK |
2023-05-08 | Ordinarie utdelning ADDV B 0.00 SEK |
2023-05-05 | Årsstämma 2023 |
2023-04-20 | Kvartalsrapport 2023-Q1 |
2023-02-23 | Bokslutskommuniké 2022 |
2022-10-27 | Kvartalsrapport 2022-Q3 |
2022-07-22 | Kvartalsrapport 2022-Q2 |
2022-05-09 | Ordinarie utdelning ADDV B 0.00 SEK |
2022-05-09 | Ordinarie utdelning ADDV A 0.00 SEK |
2022-05-06 | Årsstämma 2022 |
2022-04-22 | Kvartalsrapport 2022-Q1 |
2022-02-24 | Bokslutskommuniké 2021 |
2021-10-27 | Kvartalsrapport 2021-Q3 |
2021-07-23 | Kvartalsrapport 2021-Q2 |
2021-04-26 | Ordinarie utdelning ADDV B 0.02 SEK |
2021-04-26 | Ordinarie utdelning ADDV A 0.02 SEK |
2021-04-23 | Kvartalsrapport 2021-Q1 |
2021-04-23 | Årsstämma 2021 |
2021-02-25 | Bokslutskommuniké 2020 |
2020-10-23 | Kvartalsrapport 2020-Q3 |
2020-07-24 | Kvartalsrapport 2020-Q2 |
2020-04-27 | Ordinarie utdelning ADDV A 0.00 SEK |
2020-04-27 | Ordinarie utdelning ADDV B 0.00 SEK |
2020-04-24 | Årsstämma 2020 |
2020-04-24 | Kvartalsrapport 2020-Q1 |
2020-02-20 | Bokslutskommuniké 2019 |
2019-10-22 | Kvartalsrapport 2019-Q3 |
2019-07-23 | Kvartalsrapport 2019-Q2 |
2019-04-26 | Ordinarie utdelning ADDV A 0.00 SEK |
2019-04-26 | Ordinarie utdelning ADDV B 0.00 SEK |
2019-04-25 | Kvartalsrapport 2019-Q1 |
2019-04-25 | Årsstämma 2019 |
2019-03-12 | Extra Bolagsstämma 2019 |
2019-02-21 | Bokslutskommuniké 2018 |
2018-10-25 | Kvartalsrapport 2018-Q3 |
2018-07-26 | Kvartalsrapport 2018-Q2 |
2018-05-04 | Kvartalsrapport 2018-Q1 |
2018-04-27 | Ordinarie utdelning ADDV B 0.00 SEK |
2018-04-27 | Ordinarie utdelning ADDV A 0.00 SEK |
2018-04-26 | Årsstämma 2018 |
2018-02-16 | Bokslutskommuniké 2017 |
2017-10-31 | Kvartalsrapport 2017-Q3 |
2017-07-26 | Kvartalsrapport 2017-Q2 |
2017-05-11 | Kvartalsrapport 2017-Q1 |
2017-04-28 | Ordinarie utdelning ADDV A 0.00 SEK |
2017-04-28 | Ordinarie utdelning ADDV B 0.00 SEK |
2017-04-27 | Årsstämma 2017 |
2017-02-23 | Bokslutskommuniké 2016 |
2016-11-14 | Kvartalsrapport 2016-Q3 |
2016-08-18 | Kvartalsrapport 2016-Q2 |
2016-05-23 | Kvartalsrapport 2016-Q1 |
2016-04-27 | Ordinarie utdelning ADDV B 0.00 SEK |
2016-04-27 | Ordinarie utdelning ADDV A 0.00 SEK |
2016-04-26 | Årsstämma 2016 |
2016-02-22 | Bokslutskommuniké 2015 |
2015-11-10 | Kvartalsrapport 2015-Q3 |
2015-08-17 | Kvartalsrapport 2015-Q2 |
2015-05-22 | Kvartalsrapport 2015-Q1 |
2015-04-27 | Ordinarie utdelning ADDV A 0.00 SEK |
2015-04-24 | Årsstämma 2015 |
2015-02-19 | Bokslutskommuniké 2014 |
2014-11-05 | Kvartalsrapport 2014-Q3 |
2014-08-15 | Kvartalsrapport 2014-Q2 |
2014-05-21 | Kvartalsrapport 2014-Q1 |
2014-04-10 | Ordinarie utdelning ADDV A 0.00 SEK |
2014-04-09 | Årsstämma 2014 |
2014-02-20 | Bokslutskommuniké 2013 |
2013-11-05 | Kvartalsrapport 2013-Q3 |
2013-08-08 | Kvartalsrapport 2013-Q2 |
2013-05-20 | Ordinarie utdelning ADDV A 0.00 SEK |
2013-05-17 | Årsstämma 2013 |
2013-05-14 | Kvartalsrapport 2013-Q1 |
2013-02-21 | Bokslutskommuniké 2012 |
2012-11-06 | Kvartalsrapport 2012-Q3 |
2012-08-09 | Kvartalsrapport 2012-Q2 |
2012-05-14 | Kvartalsrapport 2012-Q1 |
2012-04-02 | Ordinarie utdelning ADDV A 0.00 SEK |
2012-03-30 | Årsstämma 2012 |
2012-02-23 | Bokslutskommuniké 2011 |
2011-11-04 | Kvartalsrapport 2011-Q3 |
2011-08-10 | Kvartalsrapport 2011-Q2 |
2011-05-05 | Kvartalsrapport 2011-Q1 |
2011-04-06 | Ordinarie utdelning ADDV A 0.00 SEK |
2011-04-04 | Årsstämma 2011 |
2011-02-07 | Bokslutskommuniké 2010 |
2010-11-04 | Kvartalsrapport 2010-Q3 |
2010-08-12 | Kvartalsrapport 2010-Q2 |
2010-05-21 | Ordinarie utdelning ADDV A 0.00 SEK |
2010-05-20 | Årsstämma 2010 |
2010-05-06 | Kvartalsrapport 2010-Q1 |
2009-09-25 | Ordinarie utdelning ADDV A 0.00 SEK |
2009-09-24 | Årsstämma 1 |
2009-09-17 | Kvartalsrapport 2009-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
ADDvise Group AB's subsidiary MRC Systems FZE has received an order from BioGeneric Pharma, a leading factory in biotechnology based in Cairo, Egypt. The order is worth approximately USD 1.7 million. The order is an add-on-project in the ongoing project between the parties regarding design, supply, and commissioning of clean room environment to be used for production of mRNA-vaccine. BioGeneric Pharma has been selected by the World Health Organization (WHO) to be the first technology transfer recipient of mRNA-vaccine hub in Egypt for distribution in Africa. Delivery of the order is planned to take place during Q2 2023. We are happy to contribute with our knowledge and expertise in the clean room space.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Important information:
This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on November 24, 2022, at 16:00 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.